Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"Tau immunotherapy: Hopes and hindrances".
Shahpasand K, Sepehri Shamloo A, Nabavi SM, Ping Lu K, Zhen Zhou X. Shahpasand K, et al. Hum Vaccin Immunother. 2018 Feb 1;14(2):277-284. doi: 10.1080/21645515.2017.1393594. Epub 2017 Dec 1. Hum Vaccin Immunother. 2018. PMID: 29049003 Free PMC article.
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.
Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen CH, Yao Y, Lin YM, Driver JA, Sun Y, Wei S, Luo ML, Albayram O, Huang P, Rotenberg A, Ryo A, Goldstein LE, Pascual-Leone A, McKee AC, Meehan W, Zhou XZ, Lu KP. Kondo A, et al. Among authors: shahpasand k. Nature. 2015 Jul 23;523(7561):431-436. doi: 10.1038/nature14658. Epub 2015 Jul 15. Nature. 2015. PMID: 26176913 Free PMC article.
cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder.
Naserkhaki R, Zamanzadeh S, Baharvand H, Nabavi SM, Pakdaman H, Shahbazi S, Vosough M, Ghaedi G, Barzegar A, Mirtorabi D, Hedayatshodeh M, Ehsani E, Falahati M, Hajipour MJ, Shahpasand K. Naserkhaki R, et al. Among authors: shahpasand k. ACS Chem Neurosci. 2019 Mar 20;10(3):1214-1221. doi: 10.1021/acschemneuro.8b00629. Epub 2019 Jan 23. ACS Chem Neurosci. 2019. PMID: 30644730
The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic.
Pourhamzeh M, Joghataei MT, Mehrabi S, Ahadi R, Hojjati SMM, Fazli N, Nabavi SM, Pakdaman H, Shahpasand K. Pourhamzeh M, et al. Among authors: shahpasand k. Cell Mol Neurobiol. 2021 Aug;41(6):1339-1354. doi: 10.1007/s10571-020-00906-2. Epub 2020 Jul 22. Cell Mol Neurobiol. 2021. Retraction in: Cell Mol Neurobiol. 2024 Mar 21;44(1):29. doi: 10.1007/s10571-024-01468-3 PMID: 32696288 Retracted.
Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
Samimi N, Sharma G, Kimura T, Matsubara T, Huo A, Chiba K, Saito Y, Murayama S, Akatsu H, Hashizume Y, Hasegawa M, Farjam M, Shahpasand K, Ando K, Hisanaga SI. Samimi N, et al. Among authors: shahpasand k. Neurobiol Aging. 2021 Dec;108:72-79. doi: 10.1016/j.neurobiolaging.2021.08.011. Epub 2021 Aug 21. Neurobiol Aging. 2021. PMID: 34536819
Pathogenic cis p-tau levels in CSF reflects severity of traumatic brain injury.
Mohsenian Sisakht A, Karamzade-Ziarati N, Jahanbakhshi A, Shahpasand K, Aghababaei S, Ahmadvand O, Azar M, Fattahi A, Zamanzadeh S. Mohsenian Sisakht A, et al. Among authors: shahpasand k. Neurol Res. 2022 Jun;44(6):496-502. doi: 10.1080/01616412.2021.2022921. Epub 2022 Jan 3. Neurol Res. 2022. PMID: 34979886
COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran.
Nabavi SM, Mehrabani M, Ghalichi L, Nahayati MA, Ghaffari M, Ashtari F, Mohammadianinejad SE, Karimi S, Faghani L, Yazdanbakhsh S, Najafian A, Shahpasand K, Vosough M. Nabavi SM, et al. Among authors: shahpasand k. Vaccines (Basel). 2022 Jan 17;10(1):135. doi: 10.3390/vaccines10010135. Vaccines (Basel). 2022. PMID: 35062796 Free PMC article.
58 results